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Abstract
AIM: The purpose of the current article is to study the state of the intestinal microflora in the context of chronic 
colonic stasis and assesses the methods of its correction by means of siphon enema and probiotics’ implication 
(bifidumbacterin and lactobacterin) to prevent the development of HAEC. 
METHODS: This study was conducted in the Astana City Children’s Hospital No. 2 and involved 60 children who 
applied for medical help with symptoms of chronic constipation. They were admitted to the hospital in a planned or 
emergency manner with suspected Hirschsprung’s disease in the period from 2015 to 2017, after approval of the 
Ethics Committee. An X-ray contrast study of the large intestine (irrigography) was performed in all the children 
for a diagnostic purpose. The following parameters of the state of the large intestine were studied: The function 
of the ileocecal valve (Bauhin’s valve), the diameter and shape of the large intestine, the presence of pathological 
formations, and symptoms of intestinal obstruction. Statistical analysis was carried out using Student’s test for 
dependent and independent samples by means of the BioStat Software. 
RESULTS: After treatment, the bacteriological examination of stool samples demonstrated an increase in the 
number of beneficial microorganisms and a decrease in the number of opportunistic microorganisms. The growth 
in the number of patients with the normal intestinal microflora (14 patients – 70%) was observed along with the 
reduction in the number of patients with intestinal dysbiosis, with a statistically significant difference (p < 0.001). 
CONCLUSION: The developed method of correcting the quantitative composition of the intestinal microflora is very 
effective and can be implemented in clinical practice.
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 Introduction
Hirschsprung’s disease is a congenital 
malformation of the colon with a lack or absence of 
ganglion cells in the intestinal segment, manifested 
mainly in symptoms of chronic colonic stasis. The 
reported incidence of the disease is 1:5000 among 
newborns [1], [2], [3]. Despite improved surgical results, 
complications of the disease occur with a frequency of 
22.7% to 38.5% [4].
The most severe complication of Hirschsprung’s 
disease is Hirschsprung-associated enterocolitis 
(HAEC). HAEC occurs against the background of 
pronounced local immune perturbation of the intestinal 
wall and microbiocenosis disturbance, resulting in the 
development of pathogenic microflora and leading 
to the disorder of microcirculation with subsequent 
perforation of the intestinal wall and development of 
peritonitis [5], [6], [7], [8]. Complications can develop 
both before and after surgical treatment. The incidence 
of enterocolitis before surgery varies from 6% to 50% 
of cases, while after surgery – from 2% to 35% [9]. 
The lack of methods to correct these disorders leads 
to complications in the anastomosis zone in 10–15% of 
cases [10]. The mortality rate remains high – 2.6–12.0%, 
especially in young children – 31–35% [11], [12], [13].
The available data show that the prevention 
of HAEC remains a relevant issue. This work aimed 
at studying the state of the intestinal microflora in 
the context of chronic colonic stasis and assessing 
the methods of its correction by siphon enema and 
probiotics (bifidumbacterin and lactobacterin) to prevent 
the development of HAEC. The proposed method was 
not used before, so there are no scientific studies on 
the peculiarities of implication and the obtained results.
Materials and Methods
The prospective study was conducted in the 
Astana City Children’s Hospital No. 2, involving 60 
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children who applied for medical help with symptoms of 
chronic constipation. They were admitted to the hospital 
in a planned or emergency manner with suspected 
Hirschsprung’s disease during the period from 2015 to 
2017, after approval of the Ethics Committee (Extract 
from the No. 5 min of the Ethics Committee meeting).
The age of the children ranged from 2 months 
to 14 years. There were 36 boys (60%) and 24 girls 
(40%). The distribution of patients by age and gender is 
presented in Table 1.
Table 1: Distribution of children by age and gender
Age/gender Boys Girls
1–6 months 2 1
6–12 months 3 1
1–3 years old 8 7
3–6 years old 11 9
6–11 years old 10 6
Older than 11 years 2 0
Total 36 24
For diagnostic purposes, all the children 
underwent an X-ray contrast study of the large intestine 
(irrigography). According to the results of irrigography, 
they were divided into the following nosological forms 
(Figure 1).
Figure 1: Results of irrigography
The study was conducted in two stages:
1st stage – analysis of a series of cases
To study the effect of bowel cleansing 
by means of a siphon enema on the quantitative 
composition of the intestinal microflora in chronic 
colonic stasis, a series of cases have been analyzed. 
The bacteriological examination of stool samples 
showed that the number of normal intestinal microflora 
microorganisms (bifidobacteria, lactic acid bacteria, 
and E. coli with normal enzyme activity) in patients 
with symptoms of chronic colonic stasis was below the 
minimum normal values. Before the administration of 
siphon enemas, such opportunistic microorganisms as 
hemolyzing Escherichia coli, Staphylococcus aureus, 
lactose-negative E. coli, enterococci, Proteus mirabilis, 
and Candida yeast-like fungi were detected during 
the bacteriological examination of stool samples. To 
prepare the large intestine for irrigography and surgical 
intervention, siphon enemas (with 1% sodium chloride 
at room temperature) were administered to 20 patients 
with symptoms of chronic constipation to clean the 
intestines. The volume of fluid for enema was determined 
by the age of the patients. The patients had indications 
for siphon enemas implication like complaints about 
the absence or delay of stool for several days over a 
long period of time with a lack of effect from a cleansing 
enema in the anamnesis.
Cleansing enemas were given to patients 
under the age of 2 months. The average duration of 
preparation was 4.2 days.
2nd stage – nonrandomized controlled 
research
At this stage, based on the results of a series 
of cases, the quantitative composition of the intestinal 
microflora was corrected. Forty patients with symptoms 
of chronic constipation were equally divided into two 
groups (with implementing of the randomization of 
patients using a random number table).
The main group involved 20 children. In 
this group, to prepare for irrigography and surgical 
intervention, the intestinal microflora was corrected by 
the proposed method. Probiotics were administered 
orally and by an enema with direct irrigation of the colon 
cavity at an age dosage given in the instructions: For 
children up to a year – 1 pack 2–3 times a day, from a 
year and older – 1 pack 3–4 times a day.
The control group involved 20 children. They 
received probiotics only enterally.
Bifidumbacterin (containing live bifidobacteria 
at no <50 million CFU/g) and lactobacterin (containing at 
least 10 million live acidophilic lactobacilli) preparations 
were used as a probiotic medicine in the form of powder:
• Bifidumbacterin forte regulates the balance 
of the intestinal microflora. The effect comes 
from the high concentration of bifidobacteria 
occluded on absorbent carbon particles, being 
antagonists of a wide range of pathogenic 
(including Shigella spp., Salmonella spp., and 
S. aureus), and opportunistic microorganisms 
(including Proteus spp. and Klebsiella spp.). It 
is produced by JSC “Firma Vitafarma,” Russia.
• Lactobacterin (powder) includes live 
lactobacilli with antagonistic activity against 
a wide range of pathogenic and opportunistic 
bacteria (including staphylococci, Proteus, 
and enteropathogenic E. coli), normalizes the 
digestive activity of the gastrointestinal tract, 
improves metabolic processes, and promotes 
the restoration of natural immunity. It is 
produced by Microgen NPO, Russia.
The average duration of treatment was 
11.3 days for the main group and 11.2 days for the 
control group.
The statistical processing of the results was 
carried out using Student’s test for dependent and 
independent samples by means of the BioStat Software.
B - Clinical Sciences Gastroenterohepatology
582 https://www.id-press.eu/mjms/index
Results
After the administration of siphon enemas 
at the first stage of the survey (is described in details 
above), the bacteriological examination of stool samples 
showed a marked decrease in the number of beneficial 
microorganisms of the intestinal microflora with a 
statistically significant difference (p < 0.001) (Table 2).
As can be seen from Table 2, in the period 
after the administration of siphon enemas, there was 
a decrease in the number and CFU/g concentrations 
of opportunistic microorganisms in the intestine 
(hemolyzing E. coli, S. aureus, lactose-negative E. coli, 
enterococci, and Candida yeast-like fungi). At the same 
time, there was a decrease in the number of beneficial 
microorganisms (bifidobacteria, lactic acid bacteria, 
and E. coli with normal enzyme activity).
At the second stage in the period before 
the correction of the quantitative composition of the 
intestinal microflora, the results of the bacteriological 
examination of stool samples in both groups 
corresponded to the results of the first stage before 
the administration of siphon enemas: A decrease in 
the number of microorganisms of the obligate intestinal 
microflora and the detection of certain species of 
opportunistic microorganisms.
The normalization of the number of beneficial 
microorganisms and the reduction in the number of 
opportunistic microorganisms (Table 3) was observed 
in patients of the main group after treatment by the 
developed method.
After treatment, the concentration of all kinds 
of beneficial microorganisms in the intestine, namely 
bifidobacteria, lactic acid bacteria, and E. coli with normal 
enzyme activity, increased to normal values with a 
statistically significant difference: p < 0.001, p < 0.01, and 
p < 0.05, respectively. A statistically significant decrease 
in the concentration of opportunistic enterobacteria in 
the intestine such as hemolytic active E. coli, lactose-
negative E. coli, and P. mirabilis was revealed.
In the bacteriological examination of stool 
samples obtained after treatment in the control group 
of patients, despite a slight improvement in the ratio of 
beneficial microorganisms in the intestine, the number 
of opportunistic microorganisms (S. aureus, Klebsiella 
pneumoniae, Citrobacter diversus, and P. mirabilis) 
increased (Table 4).
Despite treatment, there was a decrease 
of bifidobacteria with obvious statistical significance 
(p < 0.001). Other types of beneficial microorganisms 
(lactic acid bacteria, E. coli with normal enzyme activity) 
increased. However, the statistical processing revealed 
that these parameters had no significant difference 
(p > 0.05) and did not reach the normal level (p < 0.001).
When analyzing the number of opportunistic 
enterobacteria in the control stool, one can note an 
increase of pathogens above the norm and concentration 
in the intestine with the appearance of associations 
between them with a statistically significant difference 
(p < 0.001).
A comparative analysis of the results of the 
bacteriological examination of the intestinal microflora in 
patients of the main and control groups revealed that the 
Table 2: Results of the study of the intestinal microflora before and after administration of siphon enemas
Microorganisms Norm in children (Industry standard 
91500.11.0004-2003)
Number of microorganisms before 
administration of siphon enemas (n=20)
Number of microorganisms after 
administration of siphon enemas (n=20)
р
М ± m М ± m
Bifidobacteria 109–1011 CFU/g 2,377×108 ± 9,0×107 CFU/g### 2,2375×106 ± 9,17×105 CFU/g### р<0,001
Lactic acid bacteria 106–108 CFU/g 5,95×105 ± 1,05×105 CFU/g### 5,455×104 ± 1,08×104 CFU/g### р<0,001
E. coli with normal enzyme activity 107-108 CFU/g 3,25×106 ± 9,24×105 CFU/g### 2,8×105 ± 8,4×104 CFU/g### р<0,01
Opportunistic enterobacteria Norm in children (Industry standard 
91500.11.0004-2003)
Number of patients with bacteria above 
the norm
Number of patients with bacteria above 
the norm
p
CFU/g аbs (%) CFU/g аbs (%)
Hemolytic active E. coli 0 105 1 (2) - - р=0,000
S. aureus 0 105 1 (2) - - р=0,000
Candida yeast-like fungi <103–104 105 2 (10) 105 1(2) р>0,05
Lactose-negative E. coli <105 106 1 (2) - - р=0,000
Enterococci and P. mirabilis 0 105 1 (2) 104*** 1 (2) р<0,001
1.# – degree of reliability in relation to the norm:
2.# – degree of reliability at p<0.05; ## – degree of reliability at p<0,01; ### – degree of reliability at p<0,001; *** – degree of reliability at p<0.001 between the value groups in CFU/g, abs – absolute value
Table 3: Results of the study of the intestinal microflora before and after treatment of patients in the main group
Microorganisms Norm in children (Industry standard 
91500.11.0004-2003)
Number of microorganisms 
before treatment (n=20)
Number of microorganisms after 
treatment (n=20)
р
М ± m М ± m
Bifidobacteria 109–1011 CFU/g 1,2025×108 ± 6,9×107 CFU/g### 1,18×109 ± 4,85×108 CFU/g р<0,001
Lactic acid bacteria 106–108 CFU/g 7,75×105 ± 8,8×104 CFU/g### 2,62×107 ± 8×106 CFU/g р<0,01
E. coli with normal enzyme activity 107–108 CFU/g 2,53×106 ± 9,67×105 CFU/g### 3,205×107 ± 9×106 CFU/g р<0,05
Opportunistic enterobacteria <104 Number of patients with 
bacteria above the norm
Number of patients with bacteria above 
the norm
p
CFU/g abs (%) CFU/g abs (%)
Hemolytic active E. coli 0 107*** 2 (10) 104*** 1 (5) р>0,05
S. aureus 0 104 1 (5) - - р=0,000
Lactose-negative E. coli <104 107*** 1 (5) 105*** 1 (5) р>0,05
P. mirabilis <104 106** 1 (5) 105** 1 (5) р>0,05
Candida yeast-like fungi and enterococci 0 105 1 (5) - - р=0,000
1.# – degree of reliability in relation to the norm:
-#degree of reliability at р<0,05; ##degree of reliability at p<0,01; ### – degree of reliability at p<0,001; * – degree of reliability of the values expressed in CFU/g when compared with the corresponding values of another 
group: *degree of reliability at р<0,05; **degree of reliability at p<0,01; ***degree of reliability at p<0,001;
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number of microorganisms in stool samples significantly 
differed in each group with a statistically significant 
difference. The data obtained in this comparative analysis 
for the main and control groups are presented in Table 5.
Table 5 shows that before treatment, there 
was no statistically significant difference of beneficial 
and pathogenic intestinal microorganisms between 
groups (p > 0.05). While in the period after treatment, 
in patients of the main group, in comparison with the 
control group, the number of beneficial microorganisms 
was higher, and there was a decrease in the number of 
opportunistic enterobacteria (p < 0.001).
When studying the number of microorganisms 
in the intestinal microflora and comparing them with 
the degree of dysbiosis (the degrees of dysbiosis were 
determined according to the criteria of the sectoral 
standard of the Ministry of Health of Russian Federation 
“Protocol of treatment. Intestinal dysbiosis” [14]), the 
following results were revealed (Figure 2):
• Before treatment the 1st-degree intestinal 
dysbiosis was detected in 14 patients of the 
main group (70%) and in 15 patients of the 
control group (75%); 2nd-degree dysbiosis was 
detected in the remaining six patients of the 
main group (30%) and in the remaining five 
patients of the control group (25%);
• After treatment in the main group, the number 
of patients with 1st-degree intestinal dysbiosis 
decreased to three cases (15%), and the 
number of patients with 2nd-degree dysbiosis 
decreased twofold – three patients (15%), 
while the state of the intestinal microflora in 
the remaining 14 patients (70% of cases) 
corresponded to the norm;
• In the same period after treatment in the control 
group, the number of patients with 1st-degree 
intestinal dysbiosis decreased to four patients 
(20%), due to an increase in patients with 
2nd-degree dysbiosis (the remaining 16 patients 
– 80% of cases). No patients had the normal 
parameters of the intestinal flora.
Figure 2 shows that in the period before 
treatment, there was no statistically significant difference 
Table 4: Results of the study of the intestinal microflora before and after treatment of patients in the control group
Microorganisms Norm in children
(Industry standard 91500.11.0004-2003)
Number of microorganisms before 
treatment (n=20)
Number of microorganisms after 
treatment(n=20)
р
М ± m М ± m
Bifidobacteria 109–1011 CFU/g 1,207×108 ± 6,9×10 7CFU/g### 2,577×106 ± 9,19×105 CFU/g### р<0,001
Lactic acid bacteria 106–108 CFU/g 6,3х105 ± 1,05х105 CFU/g### 8,8×105 ± 1,08×105 CFU/g### p>0,05
E. coli with normal enzyme activity 107–108 CFU/g 2,08×106 ± 7,84×10 5CFU/g### 5,015×106 ± 8,86×105 CFU/g### p>0,05
Opportunistic enterobacteria <104 Number of patients with bacteria 
above the norm
Number of patients with bacteria 
above the norm
p
CFU/g abs (%) CFU/g abs (%)
Hemolytic active E. coli <104 - - 105 2 (10) р=0,000
S. aureus <104 104 2 (10) - - р=0,000
Candida yeast-like fungi <103–104 105 2 (10) 106 3 (15)*** p>0,05
Lactose-negative E. coli <104 - - 105 2 (10) р=0,000
Enterococci <105–107 107 1 (2) 108*** 3 (15)*** р<0,001
K. pneumoniae <104 - - 105 1 (2) р=0,000
C. diversus <104 - - 105 1 (2) р=0,000
P. mirabilis <104 - - 106 1 (2) р=0,000
S. aureus and K. pneumoniae 0 - - 105 2 (10) р=0,000
C. diversus and P. mirabilis 0 - - 105 1 (2) р=0,000
1. # – degree of reliability in relation to the norm:
- # – degree of reliability at р<0,05; 
- ## – degree of reliability at p<0,01;
- ### – degree of reliability at p<0,001;
2.* – degree of reliability of the values expressed in CFU/g and in percentage (%) when compared with the corresponding values of another group:
-* – degree of reliability at р<0,05; 
-** – degree of reliability at p<0,01;
-*** – degree of reliability at p<0,001;
Table 5: Comparative analysis of the results of the bacteriological examination of the intestinal microflora in patients of the main 
and control groups
Microorganisms Number of microorganisms before treatment (n=20) р Number of microorganisms after treatment(n=20) р
Main group Control group Main group Control group
М  ± m М ± m М ± m М ± m
Bifidobacteria 1,2025×108 ± 6,9×107 CFU/g 1,207×108 ± 6,9×107 CFU/g p>0,05 1,18×109 ± 4,85×108 CFU/g 2,577×106 ± 9,19×105 CFU/g р<0,001
Lactic acid 
bacteria
7,75×105 ± 8,8×104 CFU/g 6,3×105 ± 1,05×105 CFU/g p>0,05 2,62×107 ± 8×106 CFU/g 8,8×105 ± 1,08×105 CFU/g р<0,001
E. coli with normal 
enzyme activity
2,53×106 ± 9,67×105 CFU/g 2,08×106 ± 7,84×105 CFU/g p>0,05 3,205×107 ± 9×106 CFU/g 5,015×106 ± 8,86×105 CFU/g р<0,01
Opportunistic 
enterobacteria
1,555×106 ± 4,36×105 CFU/g 5,011×106 ± 5,61×105 CFU/g p>0,05 1,55×104 ± 3,1×103 CFU/g 1,5024×108 ± 3,4×107 CFU/g р<0,001
Figure 2: Distribution of patients of the main and control group by the 
degree of intestinal dysbiosis before and after treatment
Note: # – degree of reliability at p=0.000 in patients of the main 
and control groups of the normal value; *** – degree of reliability at 
p< 0.001 in patients of the main and control group with 2nd-degree 
intestinal dysbiosis).
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in the degree of intestinal dysbiosis in patients of the 
main and control groups (p > 0.05). After treatment in 
the main group, in comparison with the control group, 
there was an increase in the number of patients with the 
normal intestinal microflora (14 patients – 70%) as well 
as a decrease in the number of patients with intestinal 
dysbiosis with an obvious statistically significant 
difference (p < 0.001).
Discussion
There are studies in the already existed 
scientific literature which dwell on the usage of 
probiotics only enterally [15], [16], [17], [18]. Shen et 
al. investigated the number of lactobacilli, probiotic 
bacteria, and bifidobacteria in 30 children with 
Hirschsprung disease (10 without enterocolitis, 20 with 
enterocolitis) and 15 healthy children in the control 
group. They found a statistically significant decrease 
in the level of probiotic bacteria in all 30 children and, 
moreover, revealed that the number of bifidobacteria 
is lower in patients with enterocolitis compared with 
patients without enterocolitis. Based on this, the 
authors concluded that a deficiency of bifidobacteria 
and lactobacilli in patients with enterocolitis may lead 
to a decrease in the barrier function of the intestinal 
epithelium and may be a predisposing factor in 
the development of HAEC; hence, treatment with 
prebiotics or probiotics of such patients may have a 
positive result [19].
However, there are studies that reject such 
a conclusion. For example, El-Sawaf et al. involved 
32 patients with Hirschsprung’s disease to his study, they 
took the probiotics orally and after the calculations of 
the results, the authors concluded that taking probiotics 
does not reduce the risk of developing HAEC [20].
Against this background, the surveys on 
the implication of siphon enema and drug enema in 
the prevention of HAEC are not found at all. Hence, 
the use of probiotics by drug enema to reduce the 
risk of developing HAEC is a completely new way of 
treatment. The patent for the invention of the “Method 
for the prevention of HAEC in children” (No. 32679, 
dated 01.29.2018 by the Ministry of Justice of 
the Republic of Kazakhstan) was obtained for the 
developed method.
Limitation
The effectiveness of the developed method is 
reduced within Hirschsprung’s disease patients with 
an intestinal stoma since the presence of an intestinal 
stoma makes it difficult to perform a medicinal enema 
with probiotics of full value. Non-positive results might 
be obtained.
Conclusions
The usage of the developed method of 
biocenosis correction allows managing the negative 
effect of siphon enemas and normalizing the ratio of 
microorganisms inhabiting the large intestine. The 
method of preventing the inflammatory process in the 
intestine – HAEC – in accordance with the developed 
method of correcting the quantitative composition of the 
intestinal microflora by syphon enemas and probiotics 
is effective and can be introduced into clinical practice.
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